PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
2 October 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

Companies Stepping Up Efforts to Ensure Medicine Supply Post-Brexit

The European Medicines Agency revised the number of centrally authorized medicines for which there are concerns over Brexit-related supply disruptions.
/ read more /


After Valsartan Recalls, Regulators Grapple with Nitrosamine Contamination in APIs

The European Medicines Agency’s detection of a second nitrosamine in a sartan API is driving a deeper dive into tetrazole chemistry; root-cause investigations will now include not only valsartan and losartan, but candesartan, irbesartan, and olmesartan.
/ read more /

Check out the PharmTech Europe Supplement on APIs, Excipients, and Manufacturing, includes the CPhI Worldwide Planning Guide.

August Supplement 2018
subscribe
advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

Industry News

FDA Awards Five Grants for Advanced Biomanufacturing Research

FDA awarded nearly $3 million in grants for continuous manufacturing and other advanced manufacturing technologies as part of the agency’s efforts to ensure a robust and reliable supply of biological products.
/ read more /


Limited Therapy Access Could Hinder Personalized Cancer Treatment in the UK

The National Institute for Health and Care Excellence recently rejected National Health Service’s funding of Kymriah for diffuse large B-cell lymphoma (DLBCL) despite recognizing that the drug has significant clinical benefits.
/ read more /


More Industry News
advertisement
advertisement

Get expert insights in the white paper "External reference standards or relative response factors: Considerations for quantitation of impurities in pharmaceuticals" from Mikromol
This white paper is addressed to interested parties from pharmaceutical method development, validation and QC, and covers topics including:

  • What are relative response factors?
  • When and how do you set them up?
  • What are the limitations of relative response factors?
Read now

Regulatory News

FDA Warns of Possible Dosing Errors in Compounded Injectables

The agency announced that differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
/ read more /


Overhaul of New Drug Approval Process Moves Forward

CDER director plans to start implementation of new review practices by the end of 2018.
/ read more /


More Regulatory News

Bio/Pharma News

Novartis’ Sandoz Receives Positive CHMP Opinion for Pegfilgrastim Biosimilar

The company's biosimiliar to Amgen's Neulasta (pegfilgrastim) received a positive opinion for marketing authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
/ read more /


Novo Nordisk to Restructure R&D and Reduce Staff

The company plans to lay off approximately 400 employees to support the restructuring of its R&D organization.
/ read more /


More Bio/Pharma News

Supplier News

PharmaBlock Acquires Manufacturing Facility in China

Nanjing-based PharmaBlock Sciences acquired a GMP-compliant manufacturing facility in Shangyu, China from Porton Pharma Solutions.
/ read more /

 

GE Healthcare, Cobra Biologics, and CPI Team Up for AAV Vector Manufacturing

GE Healthcare, Cobra Biologics, and the Centre for Process Innovation (CPI) have entered into a collaboration to advance manufacturing of adeno-associated virus vectors for gene therapy.
/ read more /


More Supplier News

FEATURED TOPICS

PEER-REVIEWED RESEARCH

Rethinking Cleaning Validation for API Manufacturing

This article focuses on applying new and traditional techniques to design a cleaning process, ensure the surfaces are clean, and develop rinse solution analysis to continuously monitor cleaning performance.
/ read more /

 

EU REGULATORY WATCH

Disputes Over SPC Waivers

The European Commission’s proposed amendment on SPC waivers has sparked opposing views from drug originators and producers of generic drugs and biosimilars.
/ read more /

ASEPTIC/STERILE PROCESSING

Risk-Averse Fill/Finish Industry Embraces Change

Single-use technologies, modular systems, and robots are on the rise.
/ read more /

MANUFACTURING

Clinical Manufacturing: Clearing Higher Hurdles

Increasingly complex trial protocols have added to IMP manufacturing challenges.
/ read more /


Product Profile

Shimadzu

LCMS-9030 Q-TOF: Effortless performance
Celebrating this year the 50th anniversary of its presence in Europe, Shimadzu emphasizes its Excellence in Science approach through the release of the new LCMS-9030 quadrupole time-of-flight liquid chromatograph mass spectrometer.
/ Read more/

Events

CPhI 2018

Madrid, Spain

9–11 October 2018

Cell & Gene Therapy 2018

London, United Kingdom

10–11 October 2018

PDA Europe Pharmaceutical Microbiology

Berlin, Germany

15–16 October 2018


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2018

This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise